Heroin Detox

Compass Detox offers 24/7 care to individuals admitted to our treatment facility for heroin detox. Prior to admission, you and your loved ones may have lots of questions about what to expect during this process. Heroin and other opiate substance are highly addictive and very dangerous. Dependence and an increased tolerance on these substances can be a recipe for disaster. Do not risk an overdose for one more day. Get the best heroin detox treatment in South Florida.

What is Heroin Withdrawal?

Heroin’s severe withdrawal symptoms make detoxing from a heroin addiction difficult. Treating heroin addiction typically requires a combination of therapy and medications to help manage symptoms of heroin withdrawal and cravings.

You will begin experiencing heroin withdrawal symptoms between 6 and 12 hours after the last heroin dose. Withdrawal from heroin may resemble withdrawal from prescription opioids. Because heroin leaves the system faster than painkillers do, withdrawal symptoms come on more quickly.

During heroin detox, withdrawal often feels like a horrible case of the flu. The worst pain and discomfort lasts about a week — about as long as a bad flu — with withdrawal symptoms peaking during the second or third day.

Depending on the level and length of use, those recovering from heroin are likely to suffer post-acute withdrawal symptoms, or PAWS for short. These symptoms include poor sleep, poor concentration, increased anxiety, depression, panic attacks, fatigue, hypersensitivity, irritability, mood swings, restlessness, and memory loss. PAWS can last anywhere from 18-24 months. However, as time goes by and you remain drug-free, the symptoms will slowly begin to diminish until they disappear altogether.

The length of withdrawal from heroin depends on several factors, some of the most important being:

  • The length of time heroin was abused
  • The amount of heroin taken each time
  • Frequency of use
  • The method of taking heroin
  • The presence of underlying medical or mental health issues

Treatment During Heroin Withdrawal

Because of the severity of heroin withdrawal symptoms, almost every study and professional will strongly suggest that someone suffering from heroin addiction not undertake the recovery process on their own. Entering a treatment facility is almost always the absolute best option for success.

A variety of effective treatments are available for heroin addiction, including both behavioral and medical. Both approaches help bring back a normal life. Although behavioral and medical treatments can be extremely useful when utilized alone, research shows that for many people, integrating both types of treatments is the most effective approach. An effective heroin detox and addiction treatment facility will have both of these approaches with ample supports built-in as well.

Medical Heroin Detox

Scientific research has established that medical treatment of “opioid use disorder” increases retention in treatment programs and decreases drug use, infectious disease transmission, and criminal activity.

When people addicted to opioids, like heroin, first quit, they undergo withdrawal symptoms (see above), which may be severe. Medications can be helpful in this heroin detoxification stage to ease cravings and other physical symptoms that can often prompt a person to relapse. Medications developed to treat opioid use disorders work through the same opioid receptors as the addictive drug, but are safer and less likely to produce the harmful behaviors that characterize a substance use disorder. Three types of medications used for heroin detox include: (1) agonists, which activate opioid receptors; (2) partial agonists, which also activate opioid receptors but produce a smaller response; and (3) antagonists, which block the receptor and interfere with the rewarding effects of opioids. A particular medication is used based on a patient’s specific medical needs and other factors.

Effective heroin detox medications include:

Methadone (Dolophine or Methadose), which is a slow-acting opioid agonist. Methadone is taken orally so that it reaches the brain slowly, dampening the “high” that occurs with other routes of administration while preventing withdrawal symptoms. Methadone has been used since the 1960s to treat heroin use disorder and is still an excellent treatment option, particularly for patients who do not respond well to other medications. Methadone is only available through approved outpatient treatment programs, where it is dispensed to patients on a daily basis.

Buprenorphine (Subutex) is a partial opioid agonist. Buprenorphine relieves drug cravings without producing the “high” or dangerous side effects of other opioids. Suboxone is a novel formulation of buprenorphine that is taken orally or sublingually (under the tongue) and contains naloxone (an opioid antagonist) to prevent attempts to get high by injecting the medication. If a person with a heroin use disorder were to inject Suboxone, the naloxone would induce withdrawal symptoms, which are averted when taken orally as prescribed. The FDA approved buprenorphine in 2002, making it the first medication eligible to be prescribed by certified physicians through the Drug Addiction Treatment Act. This approval eliminates the need to visit specialized treatment clinics, thereby expanding access to treatment for many who need it. Additionally, the Comprehensive Addiction and Recovery Act (CARA), which was signed into law in July 2016, temporarily expands prescribing eligibility to qualifying nurse practitioners and physician assistants to prescribe buprenorphine-based drugs for medication-assisted treatment through October 1, 2021.

In February 2013, the FDA approved two generic forms of Suboxone, making this heroin addiction treatment option more affordable. The FDA approved a 6-month subdermal buprenorphine implant in May 2016 and a once-monthly buprenorphine injection in November 2017, which eliminates the treatment barrier of daily dosing.

Naltrexone (Vivitrol) is an opioid antagonist. Naltrexone blocks the action of opioids, is not addictive or sedating, and does not result in physical dependence; however, patients often have trouble complying with the treatment, and this has limited its effectiveness. In 2010, the injectable long-acting formulation of naltrexone (Vivitrol) received FDA approval for a new indication for the prevention of relapse to opioid dependence following opioid detoxification. Administered once a month, Vivitrol may improve compliance by eliminating the need for daily dosing.